GM John Mon and Dr. Katz of Medifocus, Inc. (OTCQB: MDFZF)

Oct 31, 2018, 12:30 PM

GM John Mon and Dr. Katz of Medifocus, Inc. (OTCQB: MDFZF)(TSX.v: MFS), join the show to discuss in detail their patented medical technologies, the APA 1000 Breast Cancer Treatment System and the FDA approved Prolieve Thermodilatation System.

OTCQB: MDFZF # TSX.v: MFS # focused microwave energy # cancer treatments # tumors # treatment of BPH # Adaptive Phased Array # catheter-basis focused heat technology # Endo-thermotherapy Platform # fully developed technology platforms # Health Canada # licensed # Microwave Focusing Platform-invented by MIT # Phase 3 Trials